About Cyrano Therapeutics
Cyrano Therapeutics is a company based in Washington (United States) founded in 2014.. Cyrano Therapeutics has raised $25.88 million across 4 funding rounds from investors including Florida Opportunity Fund, Lumira Ventures and Remiges Ventures.
- Headquarter Washington, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25.88 M (USD)
in 4 rounds
-
Latest Funding Round
$9 M (USD), Series B
Jan 16, 2024
-
Investors
Florida Opportunity Fund
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Cyrano Therapeutics
Cyrano Therapeutics has successfully raised a total of $25.88M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $9 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $9.0M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series B - Cyrano Therapeutics | Valuation | Florida Opportunity Fund , Lumira Ventures |
|
| Dec, 2020 | Amount | Series A - Cyrano Therapeutics | Valuation | Remiges Ventures , Lumira Ventures |
|
| Nov, 2020 | Amount | Series A - Cyrano Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cyrano Therapeutics
Cyrano Therapeutics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Florida Opportunity Fund, Lumira Ventures and Remiges Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fund-of-funds and VC investor funding companies in the US
|
Founded Year | Domain | Location | |
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Founded Year | Domain | Location | |
|
Remiges Ventures is engaged in biotech venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cyrano Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cyrano Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cyrano Therapeutics Comparisons
Competitors of Cyrano Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cyrano Therapeutics
When was Cyrano Therapeutics founded?
Cyrano Therapeutics was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Where is Cyrano Therapeutics located?
Cyrano Therapeutics is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.
Is Cyrano Therapeutics a funded company?
Cyrano Therapeutics is a funded company, having raised a total of $25.88M across 4 funding rounds to date. The company's 1st funding round was a Series A of $4.08M, raised on Sep 19, 2018.
What does Cyrano Therapeutics do?
Cyrano Therapeutics was founded in 2014 as a biotechnology firm focused on olfactory disorders. Pharmaceutical treatments for long-term smell and taste loss, including hyposmia, are developed through research into underlying causes of dysfunction. Clinical trials are conducted to assess therapy safety and efficacy, with operations centered on restoring sensory function for affected patients.
Who are Cyrano Therapeutics's investors?
Cyrano Therapeutics has 4 investors. Key investors include Florida Opportunity Fund, Lumira Ventures, Remiges Ventures, and DORAHOKI.